S 1712 DISARM Act of 2019 Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019
US Congress 116th Congress
DISARM Act of 2019 Developing an Innovative Strategy for Antimicrobial Resistant Microorganisms Act of 2019
S.1712
About S.1712
Requires additional payment under Medicare's inpatient prospective payment system for services that involve certain antimicrobial drugs, in accordance with specified limitations. Additionally, the Government Accountability Office must report on the barriers to developing such antimicrobial drugs and must recommend ways to address such barriers.
Bill Texts
Introduced 06/12/2019
Weigh In
No votes yet!
Cast yours now to be the first.
Votes for: 0 Votes against: 0
Spread the Word!
Gettr
Sponsors (3)
